Arthramid® Vet

Project Details

Arthramid® Vet is an unique & patented 2.5% PAAG hydrogel offering an innovative, safe solution for Veterinarians and their Clients in the management and treatment of Osteoarthritis (OA).

Registration Pending: Arthramid® Vet is currently available only under clinical trial evaluation conditions.

Unique 2.5 % PAAG Hydrogel

• 2.5% patented cross-linked polyacrylamide hydrogel (1mL)

• Permeable, homogeneous with visco-elastic properties

• Sterile, neutral, bio compatible with no chemical/biological action

Team support specialists

• A team of dedicated product specialists & Veterinarians

• A large number of relevant research and clinical publications

• Feedback from an international experienced network

World Safety Standards

• Danish manufacturer Contura International A/S exceeds world-class safety standards

Human & Vet quality production with a 15 year track record

• ISO 9001, ISO 13485 Canadian ISO 13485 CMDCAS

Regulatory

• An experienced team of veterinary specialists are handling the global, on-going regulatory process

Arthramid Vet is a unique and patented 2.5% PAAG hydrogel offering an innovative, safe and effective solution for Veterinarians in the treatment and management of Osteoarthritis (OA). Arthramid Vet is currently available only under clinical evaluation.